Review Unmasking the complexities of mucinous ovarian carcinoma

Note: mucinous/KRAS is also prevalant in colorectal cancers

Conclusions

Primary mucinous ovarian cancer should be considered separate from the other epithelial ovarian cancers. Ongoing clinical trials in this disease will likely offer improvements in chemotherapeutic agents used to treat women with primary and recurrent mucinous ovarian cancer.